{
  "DOI": "10.1007/s12687-021-00530-7",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-021-00530-7",
  "alternative-id": [
    "530"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "23 September 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "20 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 May 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "This study was approved by the Peter MacCallum Human Research Ethics Committee, Victoria, Australia (protocol no. 17/16). Verbal consent was obtained prior to audio-recording each interview. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Paul James is the director of the Parkville Familial Cancer Centre at the Peter MacCallum Cancer Centre that received funding from AstraZeneca for the Telephone Genetic Counseling Service. Bettina Meiser has a remunerated consultant role with the company AstraZeneca with respect to an unrelated project. Laura Forrest, Joanne McKinley, Rajneesh Kaur, Mary-Anne Young, and Pierre Hemming declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Hemming",
      "given": "Pierre",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4406-4327",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kaur",
      "given": "Rajneesh",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5086-0784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Meiser",
      "given": "Bettina",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-5572-0177",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "McKinley",
      "given": "Joanne",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-2493-6394",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Young",
      "given": "Mary-Anne",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4361-4657",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "James",
      "given": "Paul A.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1126-4971",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Forrest",
      "given": "Laura E.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        5,
        6
      ]
    ],
    "date-time": "2021-05-06T14:02:51Z",
    "timestamp": 1620309771000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ],
    "date-time": "2021-06-29T12:25:30Z",
    "timestamp": 1624969530000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000925",
      "award": [
        "http://purl.org/au-research/grants/nhmrc/1092856",
        "ID 1078523"
      ],
      "doi-asserted-by": "crossref",
      "name": "National Health and Medical Research Council"
    },
    {
      "DOI": "10.13039/501100001026",
      "award": [
        "PF-14-009"
      ],
      "doi-asserted-by": "crossref",
      "name": "National Breast Cancer Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        2
      ]
    ],
    "date-time": "2022-04-02T23:31:30Z",
    "timestamp": 1648942290226
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2021,
        5,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2021,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            6
          ]
        ],
        "date-time": "2021-05-06T00:00:00Z",
        "timestamp": 1620259200000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            6
          ]
        ],
        "date-time": "2021-05-06T00:00:00Z",
        "timestamp": 1620259200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00530-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-021-00530-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00530-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "449-457",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        5,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        5,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "530_CR1",
      "unstructured": "(2015) NVivo. Qualitative data analysis Software. Version 11. Doncaster, VIC, Australia, QSR International Pty Ltd."
    },
    {
      "DOI": "10.1200/JCO.2011.39.8545",
      "author": "K Alsop",
      "doi-asserted-by": "publisher",
      "first-page": "2654",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "530_CR2",
      "unstructured": "Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, Friedlander M, Fox S, Bowtell D, Mitchell G (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30(21):2654–2663",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.5694/mja14.00132",
      "author": "S Anuradha",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "issue": "5",
      "journal-title": "Med J Aust",
      "key": "530_CR3",
      "unstructured": "Anuradha S, Webb PM, Blomfield P, Brand AH, Friedlander M, Leung Y, Obermair A, Oehler MK, Quinn M, Steer C, Jordan SJ (2014) Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Med J Aust 201(5):283–288",
      "volume": "201",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60893-8",
      "author": "MW Audeh",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "9737",
      "journal-title": "Lancet",
      "key": "530_CR4",
      "unstructured": "Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N (2010) Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 376(9737):245–251",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10897-009-9238-8",
      "author": "L Baumanis",
      "doi-asserted-by": "publisher",
      "first-page": "447",
      "issue": "5",
      "journal-title": "J Genet Couns",
      "key": "530_CR5",
      "unstructured": "Baumanis L, Evans J, Callanan N, Susswein L (2009) Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction. J Genet Couns 18(5):447–463",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrc4019",
      "author": "DD Bowtell",
      "doi-asserted-by": "publisher",
      "first-page": "668",
      "issue": "11",
      "journal-title": "Nat Rev Cancer",
      "key": "530_CR6",
      "unstructured": "Bowtell DD, Böhm S, Ahmed AA, Aspuria P-J, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15(11):668–679",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1399-0004.2010.01540.x",
      "author": "AR Bradbury",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "issue": "2",
      "journal-title": "Clin Genet",
      "key": "530_CR7",
      "unstructured": "Bradbury AR, Patrick-Miller L, Fetzer D, Cummings SA, Forman A, Bealin L, Peterson C, Corbman M, O’Connell J, Daly MB (2011) Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clin Genet 79(2):125–131",
      "volume": "79",
      "year": "2011"
    },
    {
      "DOI": "10.1191/1478088706qp063oa",
      "author": "V Braun",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "2",
      "journal-title": "Qual Res Psychol",
      "key": "530_CR8",
      "unstructured": "Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1038/gim.2014.125",
      "author": "M Butrick",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "6",
      "journal-title": "Genet Med",
      "key": "530_CR9",
      "unstructured": "Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD (2015) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17(6):467–475",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1097/IGC.0000000000000689",
      "author": "PA Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "892",
      "issue": "5",
      "journal-title": "Int J Gynecol Cancer",
      "key": "530_CR10",
      "unstructured": "Cohen PA, Nichols CB, Schofield L, Van Der Werf S, Pachter N (2016) Impact of clinical genetics attendance at a gynecologic oncology tumor board on referrals for genetic counseling and BRCA mutation testing. Int J Gynecol Cancer 26(5):892–897",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ejhg.2014.86",
      "author": "A Crook",
      "doi-asserted-by": "publisher",
      "first-page": "152",
      "issue": "2",
      "journal-title": "Eur J Hum Genet",
      "key": "530_CR11",
      "unstructured": "Crook A, Plunkett L, Forrest LE, Hallowell N, Wake S, Alsop K, Gleeson M, Bowtell D, Mitchell G, G. The Australian Ovarian Cancer Study, Young M-A (2015) Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS). Eur J Hum Genet 23(2):152–158",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1365-2929.2006.02418.x",
      "author": "B DiCiccio-Bloom",
      "doi-asserted-by": "publisher",
      "first-page": "314",
      "journal-title": "Med Educ",
      "key": "530_CR12",
      "unstructured": "DiCiccio-Bloom B, Crabtree B (2006) Making sense of qualitative research. Med Educ 40:314–321",
      "volume": "40",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.ygyno.2015.12.020",
      "author": "SM Domchek",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "530_CR13",
      "unstructured": "Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM (2016) Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol 140(2):199–203",
      "volume": "140",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMoa0900212",
      "author": "PC Fong",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "issue": "2",
      "journal-title": "N Engl J Med",
      "key": "530_CR14",
      "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’connor MJ (2009) Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361(2):123–134",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10897-016-0022-2",
      "author": "R Forbes Shepherd",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "issue": "2",
      "journal-title": "J Genet Couns",
      "key": "530_CR15",
      "unstructured": "Forbes Shepherd R, Browne TK, Warwick L (2017) A relational approach to genetic counseling for hereditary breast and ovarian cancer. J Genet Couns 26(2):283–299",
      "volume": "26",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2011.3",
      "author": "L Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "530_CR16",
      "unstructured": "Forrest L, Delatycki M, Curnow L, Gen Couns M, Skene L, Aitken M (2012) An audit of clinical service examining the uptake of genetic testing by at-risk family members. Genet Med 14(1):122–128",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.191",
      "author": "A George",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "issue": "5",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "530_CR17",
      "unstructured": "George A, Kaye S, Banerjee S (2017) Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer. Nat Rev Clin Oncol 14(5):284",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1186/1471-2350-15-33",
      "author": "JM Hodgson",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "journal-title": "BMC Med Genet",
      "key": "530_CR18",
      "unstructured": "Hodgson JM, Metcalfe SA, Aitken M, Donath SM, Gaff CL, Winship IM, Delatycki MB, Skene LL, McClaren BJ, Paul JL, Halliday JL (2014) Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention. BMC Med Genet 15:33",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(13)62146-7",
      "author": "GC Jayson",
      "doi-asserted-by": "publisher",
      "first-page": "1376",
      "issue": "9951",
      "journal-title": "Lancet",
      "key": "530_CR19",
      "unstructured": "Jayson GC, Kohn EC, Kitchener HC, Ledermann JA (2014) Ovarian cancer. Lancet 384(9951):1376–1388",
      "volume": "384",
      "year": "2014"
    },
    {
      "DOI": "10.5014/ajot.45.3.214",
      "author": "L Krefting",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "issue": "3",
      "journal-title": "Am J Occup Ther",
      "key": "530_CR20",
      "unstructured": "Krefting L (1991) Rigor in qualitative research: The assessment of trustworthiness. Am J Occup Ther 45(3):214–222",
      "volume": "45",
      "year": "1991"
    },
    {
      "DOI": "10.1097/IGC.0b013e3182392714",
      "author": "A Lanceley",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "issue": "2",
      "journal-title": "Int J Gynecol Cancer",
      "key": "530_CR21",
      "unstructured": "Lanceley A, Eagle Z, Ogden G, Gessler S, Razvi K, Ledermann JA, Side L (2012) Family history and women with ovarian cancer: is it asked and does it matter?: an observational study. Int J Gynecol Cancer 22(2):254–259",
      "volume": "22",
      "year": "2012"
    },
    {
      "author": "P Liamputtong",
      "key": "530_CR22",
      "unstructured": "Liamputtong P, Ezzy D (2005) Qualitative research methods. Oxford University Press, South Melbourne",
      "volume-title": "Qualitative research methods",
      "year": "2005"
    },
    {
      "DOI": "10.1136/bmj.288.6428.1470",
      "author": "RJ Maxwell",
      "doi-asserted-by": "publisher",
      "first-page": "1470",
      "issue": "6428",
      "journal-title": "Br Med J (Clin Res Ed)",
      "key": "530_CR23",
      "unstructured": "Maxwell RJ (1984) Quality assessment in health. Br Med J (Clin Res Ed) 288(6428):1470",
      "volume": "288",
      "year": "1984"
    },
    {
      "DOI": "10.1097/AOG.0b013e3181da08d7",
      "author": "LA Meyer",
      "doi-asserted-by": "publisher",
      "first-page": "945",
      "issue": "5",
      "journal-title": "Obstet Gynecol",
      "key": "530_CR24",
      "unstructured": "Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945–952",
      "volume": "115",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.maturitas.2014.05.002",
      "author": "JC Oosterwijk",
      "doi-asserted-by": "publisher",
      "first-page": "252",
      "issue": "4",
      "journal-title": "Maturitas",
      "key": "530_CR25",
      "unstructured": "Oosterwijk JC, de Vries J, Mourits MJ, de Bock GH (2014) Genetic testing and familial implications in breast-ovarian cancer families. Maturitas 78(4):252–257",
      "volume": "78",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-012-9522-x",
      "author": "U Platten",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "issue": "3",
      "journal-title": "Familial Cancer",
      "key": "530_CR26",
      "unstructured": "Platten U, Rantala J, Lindblom A, Brandberg Y, Lindgren G, Arver B (2012) The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome. Familial Cancer 11(3):371–379",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2013.51.3226",
      "author": "MD Schwartz",
      "doi-asserted-by": "publisher",
      "first-page": "618",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "530_CR27",
      "unstructured": "Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang A-T, Chang Y, Graves K, Isaacs C, Wood M (2014) Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 32(7):618–626",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-010-9369-y",
      "author": "R Sutphen",
      "doi-asserted-by": "publisher",
      "first-page": "681",
      "issue": "4",
      "journal-title": "Familial Cancer",
      "key": "530_CR28",
      "unstructured": "Sutphen R, Davila B, Shappell H, Holtje T, Vadaparampil S, Friedman S, Toscano M, Armstrong J (2010) Real world experience with cancer genetic counseling via telephone. Familial Cancer 9(4):681–689",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41431-019-0390-9",
      "author": "E Tutty",
      "doi-asserted-by": "publisher",
      "first-page": "1186",
      "issue": "8",
      "journal-title": "Eur J Hum Genet",
      "key": "530_CR29",
      "unstructured": "Tutty E, Petelin L, McKinley J, Young MA, Meiser B, Rasmussen VM, Forbes Shepherd R, James PA, Forrest LE (2019) Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer. Eur J Hum Genet 27(8):1186–1196",
      "volume": "27",
      "year": "2019"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-021-00530-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Oncologists’ perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "12"
}